期刊文献+

枸橼酸氢钾钠降低草酸钙结石成石危险性的机制 被引量:12

The efficacy of potassium sodium hydrogen citrate intervention on urinary risk factors for calcium renal stone formation
在线阅读 下载PDF
导出
摘要 目的:探讨枸橼酸氢钾钠降低草酸钙结石成石危险性的机制。方法:经B超、X线、尿生化检查诊断为肾或输尿管含钙结石18例,其中肾结石16例,输尿管结石2例。测定口服枸橼酸氢钾钠前后尿生化参数进行比较。结果:口服枸橼酸氢钾钠2周时,尿pH值、枸橼酸、(可溶解钙×枸橼酸)/(总钙×草酸)明显升高,尿钙降低,与服用前比较,差异均有统计学意义(P<0.05)。24h尿中尿酸、草酸变化无统计学意义。结论:枸橼酸氢钾钠可有效降低含钙结石成石危险性。 Objective:To investigate the mechanism of potassium sodium hydrogen citrate inhibiting the formation of calcium stone. Methods:A total of 18 cases of 9 men and 9 women calcium stone formers were studied, 16 with renal stones and 2 with ureteral stones. All cases were identified by ultrasound, plain film of kidney-ureter bladder and urine biochemical examination. Collected 24 hour urine on their habitual, and after 2 weeks on potassium sodium hydrogen citrate. Results: Urine pH, 24-hour citrate excretion, the value (iCa^2+×Cit)/( TCa^2-Ox) increased; 24-hour calcium excretion with the difference being significant ( P 〈0.05) after 2 weeks treatment. But the change of 24-hour uric acid excretion, 24-hour oxalic acid excretion are insignificant ( P 〉0.05). Conclusions:Taking potassium sodium hydrogen citrate could inhibit the formation of calcium stone effectively.
出处 《临床泌尿外科杂志》 2007年第4期287-288,291,共3页 Journal of Clinical Urology
关键词 尿结石 枸橼酸氢钾钠 成石危险性 Stone Potassium sodium hydrogen citrate Risk factors
  • 相关文献

参考文献7

  • 1Mattle D,Hess B.Preventive treatment of nephrolithiasis with alkali citrate-a critical review[J].Urol Res,2005,33(2):73-79.
  • 2Robertson W G,Peacock M,Heyburn PJ,et al.Risk factors in calcium oxalate disease of the urinary tract[J].Br J Urol,1978,50:449-454.
  • 3Robertson W G,Peacock M,Heyburn P J,et al.Risk factors in calcium oxalate disease.In:Brockis G,Finalayson B,eds.Urinary Calculus[M].PSG Publishing Company,Inc.1981.265-272.
  • 4Tiselius H G.Risk formulas in calcium oxalate urolithiasis[J].world J Urol,1997,15:176-178
  • 5Tiselius H G.An improved method for the routine biochemical evaluation of patients with recurrent calcium oxalate stone disease[J].Clin Chim Acta,1982,122:409-418.
  • 6Tiselius H G.Aspects on estimation of the risk of calcium oxalate crystallization in urine.Urol Int,1991,47(4):255-259
  • 7Thamilselvan S,Byer K J,Hackett R L,et al.Free radical scavengers,catalase and superoxide dismutase provide protection from oxalate-associated injury to LLC-PK1 and MDCK cells[J].J Urol,2000,164(1):224-229.

同被引文献96

引证文献12

二级引证文献51

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部